Stay updated on KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial page.

Latest updates to the KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial page
- Check6 days agoChange DetectedRevision label in the page footer updated from v3.5.3 to v3.5.4, indicating a new version of the record history for this study. The change represents an internal update to the page's revision metadata rather than a modification to study details.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new revision entry (v3.5.3) was added to the Record History, replacing the previous revision (v3.5.2) to reflect an updated version of the study record.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision v3.5.2 was added to the study history and revision v3.5.0 was removed.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded a new revision entry v3.5.0 and deleted the previous revision v3.4.3 in the study record history.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision v3.4.3 was added and revision v3.4.2 was removed from the study record history.SummaryDifference0.1%

- Check99 days agoChange DetectedA new system revision (v3.4.2) was added to the history, and an existing government funding/operating status notice was removed; the previous revision (v3.4.1) remains listed. The changes are administrative in nature and do not affect the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

Stay in the know with updates to KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial page.